ZANTE GREG
Transactions
50
Companies
2
Filings
5
CIK
0001264949
Recent Transactions
- Sale
Common Stock, par value $0.00001 per share
2026-01-05$32.09/sh−1,500→ 189,891 total - Sale
Common Stock, par value $0.00001 per share
2026-01-05$32.30/sh−31,961→ 215,571 total - Sale
Common Stock, par value $0.00001 per share
2026-01-05$33.38/sh−13,900→ 201,671 total - Sale
Common Stock, par value $0.00001 per share
2026-01-05$34.24/sh−10,300→ 191,371 total - Award
Common Stock, par value $0.00001 per share
2026-01-02+41,000→ 215,483 total - Award
Common Stock, par value $0.00001 per share
2026-01-02+32,049→ 247,532 total - Award
- Sale
Common Stock, par value $0.00001 per share
2025-10-28$35.00/sh−6,185→ 173,592 total - Award
Common Stock, par value $0.00001 per share
2025-10-27+11,117→ 179,777 total - Sale
Common Stock, par value $0.00001 per share
2025-07-03$27.76/sh−4,266→ 168,660 total - Award
Common Stock, par value $0.00001 per share
2025-07-02+7,667→ 172,926 total - Sale
Common Stock, par value $0.00001 per share
2025-01-06$42.69/sh−45,609→ 169,959 total - Sale
Common Stock, par value $0.00001 per share
2025-01-06$43.32/sh−4,700→ 165,259 total - Award
Common Stock, par value $0.00001 per share
2025-01-03+21,667→ 215,568 total - Award
Common Stock, par value $0.00001 per share
2025-01-03+44,533→ 193,901 total - Award
- Exercise/Conversion
Common Stock, par value $0.00001 per share
2024-10-28$5.80/sh+26,000→ 230,053 total - Sale
Common Stock, par value $0.00001 per share
2024-10-28$74.56/sh−49,672→ 231,381 total - Sale
Common Stock, par value $0.00001 per share
2024-10-28$79.78/sh−6,050→ 158,539 total - Exercise/Conversion
Common Stock, par value $0.00001 per share
2024-10-28$7.77/sh+12,750→ 199,802 total - Exercise/Conversion
- Exercise/Conversion
Common Stock, par value $0.00001 per share
2024-10-28$8.52/sh+51,000→ 281,053 total - Exercise/Conversion
- Exercise/Conversion
Common Stock, par value $0.00001 per share
2024-10-28$4.68/sh+4,251→ 204,053 total - Exercise/Conversion
- Exercise/Conversion
- Sale
Common Stock, par value $0.00001 per share
2024-10-28$78.69/sh−15,825→ 164,589 total - Sale
Common Stock, par value $0.00001 per share
2024-10-28$81.44/sh−1,206→ 149,366 total - Sale
Common Stock, par value $0.00001 per share
2024-10-28$80.65/sh−7,967→ 150,572 total - Sale
Common Stock, par value $0.00001 per share
2024-10-28$76.94/sh−9,265→ 203,496 total - Sale
Common Stock, par value $0.00001 per share
2024-10-28$75.79/sh−18,620→ 212,761 total - Sale
Common Stock, par value $0.00001 per share
2024-10-28$77.68/sh−23,082→ 180,414 total - Sale
Common Stock, par value $0.00001 per share
2024-07-30$56.96/sh−12,662→ 190,526 total - Sale
Common Stock, par value $0.00001 per share
2024-07-30$57.71/sh−2,974→ 187,552 total - Sale
Common Stock, par value $0.00001 per share
2024-07-30$58.71/sh−500→ 187,052 total - Award
Common Stock, par value $0.00001 per share
2024-07-29+21,667→ 203,188 total - Award
Common Stock, par value $0.00001 per share
2024-07-29+6,667→ 181,521 total - Exercise/Conversion
- Sale
Common Stock, par value $0.00001 per share
2024-05-03$73.49/sh−3,101→ 238,509 total - Sale
Common Stock, par value $0.00001 per share
2024-05-03$75.49/sh−17,238→ 175,701 total - Exercise/Conversion
Common Stock, par value $0.00001 per share
2024-05-03$4.88/sh+30,000→ 241,610 total - Exercise/Conversion
Common Stock, par value $0.00001 per share
2024-05-03$4.68/sh+4,249→ 211,610 total - Exercise/Conversion
- Sale
Common Stock, par value $0.00001 per share
2024-05-03$76.07/sh−847→ 174,854 total - Sale
Common Stock, par value $0.00001 per share
2024-05-03$74.44/sh−45,570→ 192,939 total - Tax Payment
Common Stock, par value $0.00001 per share
2024-03-27$83.34/sh−16,610→ 207,361 total - Award
Common Stock, par value $0.00001 per share
2024-03-27+31,667→ 223,971 total - Award
Common Stock, par value $0.00001 per share
2024-03-01+31,667→ 212,397 total - Tax Payment
Common Stock, par value $0.00001 per share
2024-03-01$85.22/sh−20,093→ 192,304 total - Tax Payment
Common Stock, par value $0.00001 per share
2024-01-04$18.58/sh−13,872→ 195,730 total
Companies
2Recent Filings
5Address
C/O VIKING THERAPEUTICS, INC. 9920 PACIFIC HEIGHTS BLVD, SUITE 350
SAN DIEGO, CA, 92121